These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 23046250)
21. Self-Emulsifying Drug Delivery System of Simvastatin: Formulation Development, Optimization by Box- Behnken Design, Verma M; Nanda A; Kumar Y Recent Pat Drug Deliv Formul; 2018; 12(3):199-211. PubMed ID: 30345934 [TBL] [Abstract][Full Text] [Related]
22. In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous delivery. Wang Y; Zhang D; Liu Z; Liu G; Duan C; Jia L; Feng F; Zhang X; Shi Y; Zhang Q Nanotechnology; 2010 Apr; 21(15):155104. PubMed ID: 20332565 [TBL] [Abstract][Full Text] [Related]
23. Preparation and Optimization of Amorphous Ursodeoxycholic Acid Nano-suspensions by Nanoprecipitation based on Acid-base Neutralization for Enhanced Dissolution. Xie Y; Chen Z; Su R; Li Y; Qi J; Wu W; Lu Y Curr Drug Deliv; 2017; 14(4):483-491. PubMed ID: 27593183 [TBL] [Abstract][Full Text] [Related]
24. Development and comparison of intramuscularly long-acting paliperidone palmitate nanosuspensions with different particle size. Leng D; Chen H; Li G; Guo M; Zhu Z; Xu L; Wang Y Int J Pharm; 2014 Sep; 472(1-2):380-5. PubMed ID: 24882037 [TBL] [Abstract][Full Text] [Related]
25. Preparation of azithromycin nanosuspensions by reactive precipitation method. Hou CD; Wang JX; Le Y; Zou HK; Zhao H Drug Dev Ind Pharm; 2012 Jul; 38(7):848-54. PubMed ID: 22092042 [TBL] [Abstract][Full Text] [Related]
26. Enhance the dissolution rate and oral bioavailability of pranlukast by preparing nanosuspensions with high-pressure homogenizing method. Wang L; Hao Y; Liu N; Ma M; Yin Z; Zhang X Drug Dev Ind Pharm; 2012 Nov; 38(11):1381-9. PubMed ID: 22300415 [TBL] [Abstract][Full Text] [Related]
27. Preparation and characterization of freeze-dried 2-methoxyestradiol nanoparticle powders. Du B; Li XT; Zhao Y; A YM; Zhang ZZ Pharmazie; 2010 Jul; 65(7):471-6. PubMed ID: 20662313 [TBL] [Abstract][Full Text] [Related]
28. Solubility enhancement of simvastatin: a review. Murtaza G Acta Pol Pharm; 2012; 69(4):581-90. PubMed ID: 22876598 [TBL] [Abstract][Full Text] [Related]
29. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour. Lai F; Sinico C; Ennas G; Marongiu F; Marongiu G; Fadda AM Int J Pharm; 2009 May; 373(1-2):124-32. PubMed ID: 19429297 [TBL] [Abstract][Full Text] [Related]
30. Formulation and Evaluation of Naringenin Nanosuspensions for Bioavailability Enhancement. Gera S; Talluri S; Rangaraj N; Sampathi S AAPS PharmSciTech; 2017 Nov; 18(8):3151-3162. PubMed ID: 28534300 [TBL] [Abstract][Full Text] [Related]
31. Fabrication of amorphous curcumin nanosuspensions using β-lactoglobulin to enhance solubility, stability, and bioavailability. Aditya NP; Yang H; Kim S; Ko S Colloids Surf B Biointerfaces; 2015 Mar; 127():114-21. PubMed ID: 25660094 [TBL] [Abstract][Full Text] [Related]
32. Supersaturated self-nanoemulsifying drug delivery systems (Super-SNEDDS) enhance the bioavailability of the poorly water-soluble drug simvastatin in dogs. Thomas N; Holm R; Garmer M; Karlsson JJ; Müllertz A; Rades T AAPS J; 2013 Jan; 15(1):219-27. PubMed ID: 23180162 [TBL] [Abstract][Full Text] [Related]
33. Fabrication and characterization of glimepiride nanosuspension by ultrasonication-assisted precipitation for improvement of oral bioavailability and in vitro α-glucosidase inhibition. Rahim H; Sadiq A; Khan S; Amin F; Ullah R; Shahat AA; Mahmood HM Int J Nanomedicine; 2019; 14():6287-6296. PubMed ID: 31496686 [TBL] [Abstract][Full Text] [Related]
34. A simple and low-energy method to prepare loratadine nanosuspensions for oral bioavailability improvement: preparation, characterization, and in vivo evaluation. Yang D; Li R; Zhang F; Qin L; Peng F; Jiang S; He H; Lu X; Zhang P Drug Deliv Transl Res; 2020 Feb; 10(1):192-201. PubMed ID: 31482518 [TBL] [Abstract][Full Text] [Related]
35. Preparation and characterization of simvastatin/DMβCD complex and its pharmacokinetics in rats. Gu F; Ning J; Fan H; Wu C; Wang Y Acta Pharm; 2018 Jun; 68(2):145-157. PubMed ID: 29702479 [TBL] [Abstract][Full Text] [Related]
36. The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats. Zhang Z; Bu H; Gao Z; Huang Y; Gao F; Li Y Int J Pharm; 2010 Jul; 394(1-2):147-53. PubMed ID: 20435111 [TBL] [Abstract][Full Text] [Related]
37. Development and characterization of an orodispersible film containing drug nanoparticles. Shen BD; Shen CY; Yuan XD; Bai JX; Lv QY; Xu H; Dai L; Yu C; Han J; Yuan HL Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1348-56. PubMed ID: 24103635 [TBL] [Abstract][Full Text] [Related]
38. Honokiol nanosuspensions: preparation, increased oral bioavailability and dramatically enhanced biodistribution in the cardio-cerebro-vascular system. Han M; Yu X; Guo Y; Wang Y; Kuang H; Wang X Colloids Surf B Biointerfaces; 2014 Apr; 116():114-20. PubMed ID: 24448177 [TBL] [Abstract][Full Text] [Related]
39. Comminution of ibuprofen to produce nano-particles for rapid dissolution. Plakkot S; de Matas M; York P; Saunders M; Sulaiman B Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776 [TBL] [Abstract][Full Text] [Related]
40. Formulation, optimization and in vitro-in vivo evaluation of febuxostat nanosuspension. Ahuja BK; Jena SK; Paidi SK; Bagri S; Suresh S Int J Pharm; 2015 Jan; 478(2):540-52. PubMed ID: 25490182 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]